Acrivastine and pseudoephedrine and Hyaluronidase and trastuzumab
Determining the interaction of Acrivastine and pseudoephedrine and Hyaluronidase and trastuzumab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: acrivastine / pseudoephedrine
Brand name: Semprex-D
Synonyms: Acrivastine and Pseudoephedrine
Generic Name: hyaluronidase / trastuzumab
Brand name: Herceptin Hylecta
Synonyms: Trastuzumab and Hyaluronidase
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Acrivastine and pseudoephedrine-Hyaluronidase injection
- Acrivastine and pseudoephedrine-Hyaluronidase Injection (Human)
- Acrivastine and pseudoephedrine-Hyaluronidase Subcutaneous, Injection
- Acrivastine and pseudoephedrine-Hyate:C
- Acrivastine and pseudoephedrine-Hybrisil
- Acrivastine and pseudoephedrine-Hycamtin
- Hyaluronidase and trastuzumab-Actamin
- Hyaluronidase and trastuzumab-Actamin Maximum Strength
- Hyaluronidase and trastuzumab-Actemra
- Hyaluronidase and trastuzumab-Actemra (Tocilizumab (Intravenous))
- Hyaluronidase and trastuzumab-Actemra (Tocilizumab Auto-Injectors)
- Hyaluronidase and trastuzumab-Actemra (Tocilizumab Prefilled Syringes)